Merck Profit Margin 2006-2020 | MRK

Current and historical gross margin, operating margin and net profit margin for Merck (MRK) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Merck net profit margin as of June 30, 2020 is 22.2%.
Merck Annual Profit Margins
Merck Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $206.068B $46.840B
Merck & Co., Inc., a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through their prescription medicines, vaccines, biologic therapies and animal health products, they work with customers and operate the countries to deliver innovative health solutions. The Company also demonstrate their commitment to increasing access to health care through far-reaching policies, programs and partnerships. Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $390.711B 18.62
Roche Holding AG (RHHBY) Switzerland $297.224B 0.00
Pfizer (PFE) United States $213.583B 13.35
Novartis AG (NVS) Switzerland $190.923B 14.84
AbbVie (ABBV) United States $164.571B 10.03
Novo Nordisk (NVO) Denmark $153.274B 25.52
Eli Lilly (LLY) United States $147.622B 22.53
AstraZeneca (AZN) United Kingdom $146.834B 28.55
Sanofi (SNY) $129.239B 15.36
GlaxoSmithKline (GSK) United Kingdom $103.376B 13.56
Bayer (BAYRY) Germany $62.294B 8.98
H Lundbeck (HLUYY) Denmark $7.279B 12.65
Innoviva (INVA) United States $1.360B 6.51